TAMPA, Fla.—Oragenics Inc. released a corporate video narrated by CEO, John N. Bonfiglio, Ph.D., on the 2012 strategic direction for Oragenics. The video highlights how Oragenics is creating value by leveraging the $32B probiotic market and addressing the renewed focus on building a strong probiotic business for oral care. Bonfiglio’s commentary also highlights Oragenics’ platform technology, ProBiora3®, which was recognized by Frost & Sullivan in November 2011, and is the active ingredient used in the Company’s oral care suite of products. Bonfiglio explains how on the corporate side, the team will be executing more on its business development and sales initiatives.
“Given the evolution and sophisticated science in the probiotics marketplace, we feel educating consumers, investors and the general public on ProBiora3 is essential. The video also shares management’s vision for becoming the world leader in oral care probiotics for humans and companion pets on a more detailed level. Given the role oral care now plays in supporting overall health, the intent of the video is to broaden the awareness of probiotics for oral care and to share Oragenics' vision going forward in 2012," Bonfiglio stated.
